Dupixent 200 MG/1.14 ML syring 1.14ML
Ended Awarded Last action
- Contract number
- SPE2DR26FE8B9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,239
Award facts
- Contract value 100% obligated
- $10,239.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $10,239.33 delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 200 mg/1.14 mL syringes on December 4, 2025, with an ultimate completion date of December 5, 2025. This is a firm fixed-price, non-set-aside contract for delivery to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child order under the company's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion vehicle through December 2026 that serves as the primary pharmaceutical support mechanism for military healthcare systems worldwide.
AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, is a critical vendor for federal medical procurement and maintains extensive experience fulfilling DLA supply requirements across multiple therapeutic domains. The company's substantial IDC enables it to supply brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical devices to support Defense Health Agency operations and other federal healthcare systems globally. This delivery order for Dupixent, a biologic immunosuppressant commonly used to treat moderate-to-severe atopic dermatitis and other allergic conditions, reflects the company's ongoing role in providing specialty pharmaceutical support to military healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FE8B9?
SPE2DR26FE8B9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26FE8B9 worth?
The government has obligated $10,239 on SPE2DR26FE8B9.
Is contract SPE2DR26FE8B9 an order under another contract?
Yes. SPE2DR26FE8B9 is a delivery order under SPE2DR25D2005, an indefinite delivery contract.
Was contract SPE2DR26FE8B9 competed?
The extent of competition for SPE2DR26FE8B9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award